Study shows high engagement with digital therapy for schizophrenia spectrum disorders

Pear Therapeutics, a Boston and San Francisco-based developer of digital strategies to address a broad range of mental health conditions, has released results of a study showing promising engagement with its program Thrive, which uses a smartphone app along with medication to treat patients with schizophrenia, schizoaffective disorder and bipolar disorder.

Thrive offers 24/7 patient monitoring and support to patients (via healthcare organizations), and provides real-time interventions targeting symptoms of schizophrenia including hallucinations and delusions. It also offers support for schizophrenia-related mood disorders.

The study, published in the Journal of Medical Internet Research, followed 342 patients between the age of 18 and 60 with schizophrenia-spectrum disorders. The patients had been diagnosed with a disorder, admitted to a psychiatric hospital and subsequently discharged. Patients were given a research version of Thrive to see whether they would engage with it, and found that 74 percent of the patients were successfully able to use the digital therapy three to six months after discharge, and, on average, using the therapy for 82 percent of the weeks they had the mobile phone.

Read the full story here:

2 Likes

Good stuff. I hope to find a cure… I’ve been struggling a bit lately